Sponsored: Jubilant’s Precision Medicines Offer Safety, Therapeutic Advantages in Cancer, Immunology

Jubilant Therapeutics’s differentiated, orally bioavailable molecules address both validated and novel therapeutic targets in oncology and immunology.